COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,699 Articles (22,913 medRxiv, 8,786 bioRxiv)

Most recent first Previous |  Page 35: Articles 341-350  | Next

Chronic absenteeism in Canadian kindergarten classes, pre- and post-COVID-19, and its association with concurrent developmental vulnerability
Reid-Westoby, C., Duku, E., Gaskin, A., Janus, M.
10.64898/2026.03.04.26347661 — Posted: 2026-03-05
A macrocyclic peptide-based fusion inhibitor targeting SARS-CoV-2 Spike S2 subunit
Ohashi, H., Kawamura, T., Ohuchi, M., Kurasaki, H., Iwata-Yoshikawa, N., Hirata, Y., Moriyama, S., Shionoya, K., Nagatomo, K., Nagasawa, T., Yamamoto, J., Sudo, K., Nakamura, N., Matsui, K., Ogawa, H., Yoshida, K., Shimada, Y., Maruyama, T., Higuchi, T., Ito, S., Takahashi, Y., Kawamura, N., Reid, P. C., Murakami, M., Suzuki, T., Nagata, N., Kitamura, H., Watashi, K.
10.64898/2026.03.04.703990 — Posted: 2026-03-05
Investigating the use of human COVID-19 rapid assays to detect antibody and antigen in domesticated dogs (Canis lupus familiaris) and cats (Felis catus)
Cybulska, L. C., Hamer, S. A., Teasdale, C., Johnson, G., Hamer, G., Grassman, J.
10.64898/2026.03.04.709710 — Posted: 2026-03-05
Outburst of serotype 4 IPD after COVID-19 is driven by ST15063/GPSC162 lineage associated with high-risk behaviors and greater virulence linked to influenza H3N2 virus coinfection and cigarette smoke
Perez-Garcia, C., Llorente, J., Aguirre Alustuey, M. E., Llamosi, M., Gil, R., Lahlali, G., El-Ayache, F., Yan, V., Schotsaert, M., Del Diego, J., Cisneros, J. M., Garcia-Sastre, A., Domenech, M., Sempere, J., Yuste, J.
10.64898/2026.02.27.26346872 — Posted: 2026-03-04
Microfilaremic loiasis is associated with T cell hyporesponsiveness against SARS CoV-2
Auge-Stock, M., Okwu, D. G., More, A., Doralt, A., Bikangui, R., Boussoukou, I. P. M., Eberhardt, K. A., Sandkuhl, M., Zoleko Manego, R., Mombo Ngoma, G., McCall, M., Breloer, M., Esen, M., Addo, M., Lell, B., Veletzky, L., Adamou, R., Mackroth, M. S.
10.64898/2026.03.02.708985 — Posted: 2026-03-04
Defining the Antigenic Topology and Prospective Binding Breadth of Vaccination-induced SARS-CoV-2 Neutralizing Antibodies
Jaiswal, D., Altomare, C. G., Adelsberg, D. C., Sapse, I. A., Krammer, F., Simon, V., Ellebedy, A. H., Bajic, G.
10.64898/2026.03.03.709398 — Posted: 2026-03-04
Fluorinated RNA origami enables serum-stable nanodevices for sensing and targeting
Kristoffersen, E. L., Zwergius, N. H., Sampedro Vallina, N., Stange, A. D., Desdorf, L. M., Thomsen, S., Birkedal, V., Glück, N., Civit, L., Geary, C., Kjems, J., Valero, J., Andersen, E. S.
10.64898/2026.03.04.709525 — Posted: 2026-03-04
Exposure route drives SARS-CoV-2 infection patterns in non-human primates
Snedden, C. E., Morris, D., Friedrich, T., Lloyd-Smith, J. O.
10.64898/2026.03.03.709384 — Posted: 2026-03-04
Admission Predictors of In-Hospital Mortality and the Combined Outcome of Death or Invasive Mechanical Ventilation in Patients with COVID-19 During the Pre-Vaccination Era: A Retrospective Cohort Study
Rassi, A., Rassi, V. M., Garcia, J. V. R., Gervasio, H. M., Kobal, C. R., de Souza, F. M., Butrico, G. F. d. O., Sanchez, E. P., Rassi, F. M., Canedo, G. P., Cunha, V. R. P., Rodrigues-Filho, R. N. D., Carneiro, A. F., Rassi, G. G.
10.64898/2026.02.28.26347308 — Posted: 2026-03-03
A new mRNA antigen vaccine induces potent B and T cell responses and in vivo protection against SARS-CoV-2
Wen, J., Moon, J., Tucciarone, L., Bu, T.-H., Sun, A. Y., Miller, R., Timis, J., Wu, L., Smith, D. M., Shresta, S., Gaulton, K. J., Rana, T. M.
10.64898/2026.03.02.709177 — Posted: 2026-03-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).